Clover Biopharmaceuticals, Ltd. (HKG:2197)
2.970
+0.110 (3.85%)
Apr 29, 2026, 4:08 PM HKT
1,370% (1Y)
| Market Cap | 3.86B |
| Revenue (ttm) | 3.90M |
| Net Income (ttm) | -228.23M |
| Shares Out | 1.30B |
| EPS (ttm) | -0.18 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,711,000 |
| Average Volume | 5,550,636 |
| Open | 2.860 |
| Previous Close | 2.860 |
| Day's Range | 2.780 - 3.030 |
| 52-Week Range | 0.193 - 3.200 |
| Beta | 2.67 |
| RSI | 57.14 |
| Earnings Date | Mar 25, 2026 |